MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test
Comprehensive Genetic Testing for Congenital Heart Conditions
The MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing method provides crucial insights into genetic mutations associated with serious congenital heart defects, enabling early detection, proper management, and informed family planning decisions.
What This Test Measures and Detects
This sophisticated genetic test specifically targets mutations in the MED13L gene using Next-Generation Sequencing (NGS) technology. The MED13L gene plays a critical role in heart development during embryonic stages, and mutations in this gene have been strongly linked to:
- Transposition of the great arteries (TGA) with dextro-looping
- Congenital heart malformations affecting arterial positioning
- Genetic variations impacting cardiac chamber development
- Inherited cardiovascular conditions with complex genetic origins
The test provides comprehensive analysis of the entire MED13L gene sequence, identifying both known pathogenic variants and novel mutations that may contribute to cardiovascular abnormalities.
Who Should Consider This Genetic Test
This specialized genetic testing is recommended for individuals and families experiencing specific clinical scenarios:
- Patients with congenital heart defects: Individuals diagnosed with transposition of the great arteries or related cardiac conditions
- Family history of heart disease: Those with multiple family members affected by congenital heart abnormalities
- Unexplained cardiac symptoms: Patients presenting with complex cardiovascular symptoms without clear diagnosis
- Pregnancy planning: Couples with family history of congenital heart disease considering pregnancy
- Recurrent pregnancy loss: Individuals experiencing multiple miscarriages with suspected genetic causes
- Children with developmental delays: Pediatric patients with both cardiac and neurodevelopmental concerns
Clinical Benefits of MED13L Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Precise identification of genetic mutations causing congenital heart conditions
- Personalized Treatment Planning: Tailored medical and surgical interventions based on genetic findings
- Family Risk Assessment: Understanding inheritance patterns and recurrence risks for family members
- Reproductive Guidance: Informed family planning decisions and prenatal testing options
- Early Intervention: Opportunity for proactive management before serious complications develop
- Comprehensive Care Coordination: Integration of cardiology and genetics specialties for optimal patient outcomes
Understanding Your Test Results
Our genetic counseling team provides detailed interpretation of your MED13L gene test results:
- Positive Result: Indicates the presence of a pathogenic mutation in the MED13L gene, confirming genetic predisposition to transposition of the great arteries
- Negative Result: No mutations detected in the MED13L gene, though other genetic or environmental factors may still contribute to cardiac conditions
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing monitoring and family studies
- Carrier Status: Determines if individuals carry mutations that could be passed to offspring
All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Accessibility
We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and cardiovascular specialists ensures you receive expert care regardless of your location.
Take Control of Your Cardiovascular Health
Don’t let genetic uncertainties impact your heart health and family planning decisions. Our MED13L genetic testing provides the clarity and confidence needed for informed medical decisions. With advanced NGS technology and expert genetic counseling, you’ll receive comprehensive insights into your genetic cardiovascular risk profile.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test. Our team is ready to answer your questions and help you take the next step toward understanding your genetic cardiovascular health.
